Outcomes and Insights Products for medical-technology

With a shift toward comparative effectiveness and value-based purchasing initiatives, medical-technology companies are now competing in a healthcare ecosystem where outcomes and costs are primary factors in purchasing decisions. The ability to analyze, define and report clinical and economic outcomes is now a fundamental business requirement. Thus, a new form of analytics-based competition is emerging, requiring volumes of reliable and relevant benchmarking data.

Access to trusted outcomes information, however, is a substantial challenge. Even when information is available, a true comparative analysis of outcomes still requires adjusting for risk factors such as differences in patient populations, co-morbidities, and complexity of procedures. These complicating factors require rigorous and consistent analytic approaches.

To win in this new environment, medical product companies need to provide objective, third-party designed and validated cost and/or cost-effectiveness data to give their customers the information needed to make effective purchasing decisions. PotentiaMetrics works as a trusted third-party to cross traditional boundaries to develop multi-institutional real-world data registries which enables the company to develop unique analytic solutions and provide third party administrative solutions.

We help med-tech companies:

Capture, Integrate Data to Enhance the Evidence

  • Access clinically rich and deep real-world outcomes data from multi-institutional research base
  • Proprietary access to Individual-level, real-world evidence (RWE)
  • Unique longitudinal patient reported outcomes tools (PRO) data capture, functioning, quality of Life
  • Agreements to gather and incorporate continuous data from multiple providers
  • Large enough samples to uncover insights into treatment and individual outcomes

Employing Data Science to Uncover Insights

  • Personalized and predictive insights, derived from externally-validated, proprietary economic platforms
  • Comparative effectiveness research (CER) outcomes and costs by procedure, provider
  • Risk-adjusted outcomes and costs by procedure, provider, performance transparency
  • Member population analysis, market identification
  • Identify cost for care across the continuum and its drivers
  • Define treatment pathways
  • Cost-effectiveness, Purchase Decision Analysis, Value Based Pricing

Outcomes Measures, Incentive Design, Reporting

  • Next generation outcomes metrics, beyond adherence
  • Health risk stratification
  • Risk-adjusted outcomes information for Comparative Effectiveness & QA/QI Quality Improvement (QI)
  • Support value-based care, at-risk contract metrics determination
  • Inform outcomes-based contracts and risk-sharing agreements

Outcomes-Based Compensation, Incentives Tied to Individual Outcomes Not Limited to Compliance/Adherence

  • Longitudinal outcomes tracking
  • Precision performance metrics, survival, clinical response, events of interest, resource utilization
  • Nuanced, risk-stratified outcomes reporting
  • Outcomes reported by an independent party with requisite clinical expertise and genuine objectivity
  • Outcomes-based reporting, adjudication, compensation
  • R&D Productivity, Clinical trials optimization

Support of Healthcare Reform

  • Healthcare reform, innovation including outcomes and price transparency
  • Meet Value Based Care (VBC) requirements
  • Merit-based Incentive Payment System (MIPS), Measure Development Plan (MDP), Advanced Alternative Payment Models (APMs)
  • Bundled payment management
  • Coordination of information across boundaries to share care, accountability & risk

Cultivation of Learning Systems

  • Uncover personalized insights, Identification of various sub-populations with different needs
  • Predict high risk patients and avoid high cost events
  • Support informed, shared-decision making, personalized treatment, improved adherence, outcomes
  • Tools and platforms that enable collaboration across providers, patients and payers
  • Reduce procedures, claims paid, complications, improved management of end of life care
  • Increase patient and provider satisfaction
  • Benchmarking, risk adjusted clinical & economic outcomes, volumes and other key metrics
  • Support for patient safety, quality Improvement efforts and needs of clinicians
  • Improve target price under bundled payments